Early intervention in bipolar disorder
|
|
- Jeremy Julius Neal
- 5 years ago
- Views:
Transcription
1 Early intervention in bipolar disorder Lars Vedel Kessing, professor, DMSc. Psychiatric Center Denmark 1
2 Disclosure: Lars Vedel Kessing has within recent three years been a consultant for Lundbeck and AstraZeneca. 2
3 Early intervention in bipolar disorder? A number of randomised trials have investigated the effect of combined pharmacological and psychological interventions and various healthservice interventions in bipolar disorder.but none of the studies have specifically investigated the effect in the early stages of bipolar disorder. 3
4 7 indications from observational studies that early intervention may improve course and outcome 1. Progressive course of illness with increasing risk of recurrence for every new episode (Kessing et al, 1998, 2004) 4
5 Progressive course of illness with increasing risk of recurrence for every new episode Kessing et al, BJP 2004,185:
6 7 indications from observational studies that early intervention may improve course and outcome 1. Progressive course of illness with increasing risk of recurrence for every new episode (Kessing et al, 1998, 2004) 2. Delay to first treatment is associated with more time depressed, greater severity of depression, greater number of episodes and more days of ultradian cycling (Post et al, 2010) 6
7 7 indications from observational studies that early intervention may improve course and outcome 1. Progressive course of illness with increasing risk of recurrence for every new episode (Kessing et al, 1998, 2004) 2. Delay to first treatment associated with more time depressed, greater severity of depression, greater number of episodes, more days of ultradian cycling (Post et al, 2010) 3. Response to lithium monotherapy decreases with the occurrence of multiple prior episodes (Kessing et al, 2011) 7
8 7 indications from observational studies that early intervention may improve course and outcome 1. Progressive course of illness with increasing risk of recurrence for every new episode (Kessing et al, 1998, 2004) 2. Delay to first treatment associated with more time depressed, greater severity of depression, greater number of episodes, more days of ultradian cycling (Post et al, 2010) 3. Response to lithium monotherapy decreases with the occurrence of multiple prior episodes (Kessing et al, 2011) 4. The rate of response to lithium is increased when started at first psychatric contact rather than at later contacts (Kessing et al, 2014) 8
9 Rate of non-response to lithium when started following first versus later contacs N= 4714: HR= 0.73, 95%CI: , p< ; Kessing et al, British Journal of Psychiatry, 2014 Jul 10. 9
10 7 indications from observational studies that early intervention may improve course and outcome (con t) 5. Mood stabilizers prescribed for bipolar disorder may have neuroprotective abilities (Manji et al, 2000; Fountoulakis et al, 2008) 10
11 7 indications from observational studies that early intervention may improve course and outcome (con t) 5. Mood stabilizers prescribed for bipolar disorder may have neuroprotective abilities (Manji et al, 2000; Fountoulakis et al, 2008) 6. The prevalence of cognitive dysfunction may increase with affective episodes and the risk of dementia seems increased for patients with bipolar disorder (Silva et al, 2013) 11
12 Forest plot of studies that evaluated bipolar disorder as a risk factor for dementia or Alzheimer s disease. Studies are organised from high quality (top) to lower quality (bottom). Silva J et al. BJP2013;202: by The Royal College of Psychiatrists 12
13 7 indications from observational studies that early intervention may improve course and outcome (con t) 5. Mood stabilizers prescribed for bipolar disorder may have neuroprotective abilities (Manji et al, 2000; Fountoulakis et al, 2008) 6. The prevalence of cognitive dysfunction may increase with affective episodes and the risk of dementia seems increased for patients with bipolar disorder (Silva et al, 2013) 7. Patients may profit from psychoeducation before potential cognitive disturbances may occur during the long-term course of illness (Berk et al, 2007). 13
14 Specialized mood disorder clinics? It has been claimed that specialized bipolar units and programs such as, e.g., the Bipolar Disorders Programme at the Barcelona Hospital Clinic are needed to improve outcome and advance research in bipolar disorder (Vieta, 2012)..but there is no randomised trial on the effects of such specialized units. 14
15 Treatment in a specialised outpatient mood disorder clinic versus standard treatment in the early course of bipolar disorder: a randomised multicenter clinical trial within The Mental Health Services in the Capital Region of Danmark Lars Vedel Kessing, Hanne Vibe Hansen, Ellen Margrethe Christensen, Henrik Dam, Christian Gluud, Jørn Wetterslev, and The Early Intervention Affective Disorders (EIA) Trial Group* * Members of the EIA Trial Group also encompass Klaus Damgård Jakobsen, Ejnar Bundgaard Larsen, Martin Balslev Jørgensen, Maj Vinberg, Rikke Engel, Flemming Mørkeberg Nilsson, Nana Hengstenberg, Birgitte Bjerg Bendsen, Hans Mørch Jensen, Rie Lambæk Mikkelsen, Birgit Straasø, Jens Abraham. 15
16 Early intervention in bipolar disorder Aim: In a RCT to investigate whether treatment in a specialized bipolar unit program, combining optimised pharmacological treatment with group psychoeducation, early in the course of illness among patients discharged from their first hospitalisations for bipolar disorder improve long-term outcome compared with standard psychiatric outpatient treatment. 16
17 Early intervention in bipolar disorder Specialized bipolar unit 2-year program: Optimised pharmacological treatment: evidence focused treatment in accordance with the guidelines from the British Association for Psychopharmacology, 2009 with focus on mood stabilising agents (lithium, valproate, lamictal and atypical antipsychotics) 3 sequential groups A) settling-in group: focus on the current clinical status and beliefs and experiences in relation to the recent hospitalisation. B) following remission: psychoeducation once a week for 15 weeks (shortened version ad modus F Colom) C) discharge group: learn to live and identify early warning signals 17
18 Early intervention in bipolar disorder Inclusion: Patients discharged from their first, second, or third hospitalisation from an inpatient psychiatric ward with an ICD- 10 diagnosis of single manic episode or bipolar disorder as the primary diagnosis. Comorbidity with alcohol or substance abuse and other psychiatric disorders were allowed. Age between 18 and 70 year old. Exclusion: moderate or severe dementia poor understanding of Danish any kind of commitment 18
19 Early intervention in bipolar disorder Primary outcome Re-admission to psychiatric ward after discharge from the index hospitalisation. Data on re-hospitalisation were obtained from the Danish Psychiatric Central Register Secondary outcomes Use of mood stabilizers (lithium or anticonvulsants), atypical antipsychotics and/or antidepressants. Tertiary outcome Satisfaction with care (Verona Service Satisfaction Scale- Affective Disorder (VSSS-A)) 19
20 Basic characteristics The mood disorder clinic Standard Treatment N Sex, Female (%) 44 (61.1) 42 (48.8) Median age at randomisation (quartiles) Number of patients with or without previous admission before index hospitalisation Without (%) With (%) 37.6 ( ) 35.2 ( ) 41 (56.9) 31 (43.1) 40 (46.5) 46 (53.5) 20
21 Early intervention in bipolar disorder Standard care local community mental health centre 56.5% private psychiatrist 24.7% local psychiatrist at the discharging ward 15.3% the general practitioner 3.5% 21
22 Time to re-admission for patients treated in a mood disorder clinic versus standard care. 1 p= Adjusted for age, sex, psychiatric centre, and number of previous psychiatric admissions: HR 0.60, 95% CI 0.37 to 0.98 p= Kessing et al, British Journal of Psychiatry 2013, 202:
23 Time to re-admission for patients treated in a mood disorder clinic versus standard care. 2 Kessing et al, British Journal of Psychiatry 2013, 202:
24 Time to re-admission for patients treated in a mood disorder clinic versus standard care. 3 Kessing et al, British Journal of Psychiatry 2013, 202:
25 Early intervention in bipolar disorder Cumulated duration of hospitalisations (median (quartiles)) Mood disorder clinic Standard care P 33.0 days ( ) 49.0 days ( )
26 Early intervention in bipolar disorder Mood disorder clinic Standard care P Use of : Mood stabilizer (lithium / anticonv., %) Antipsychotic (%) Antidepressants (%)
27 Early intervention in bipolar disorder Mood disorder clinic Standard care P Satisfaction with intervention (VSSS-A) (SD: 16.9) (SD: 31.6)
28 Two-year treatment mean costs per patient in the Mood disorder clinic versus standard care (euro). Total direct net costs when including saved hospitals beds: Treatment in the mood disorder clinic was 3,194 euro less per patient than for standard care, corresponding to 11 % of the costs for standard care. 28
29 29 patients between 18 and 25 years of age Patients between 18 and 25 years (HR 0.33, 95% CI 0.10 to1.07; p=0.064) Patients 26 years or older (HR 0.68, 95% CI 0.40 to1.14, p=0.14). 1 Kessing et al, K Journal Affective Disorders, 2014 Jan; :
30 29 patients between 18 and 25 years of age Patients between 18 and 25 years (HR 0.33, 95% CI 0.10 to1.07; p=0.064) Patients 26 years or older (HR 0.68, 95% CI 0.40 to1.14, p=0.14). 2 Younger adults treated in the mood disorder clinic used mood stabilizers and antipsychotics more than those treated in standard care. Kessing et K al, Journal Affective Disorders, 2014 Jan; :
31 Early intervention in young patients with bipolar disorder Young adults with bipolar disorder may benefit even more than older adults from early intervention combining pharmacological treatment and group psychoeducation. Kessing et al, J Affect Disorders, 2014 Jan; :
32 Limitations Early intervention? - Half of the patients had had their first hospitalisation ever. - High median age of 35.6 years at inclusion in the study (although 25% were below 28 years and 25% above 47 years). Generalisation? - To bipolar I patients with the more severe disorders leading to hospitalisation 32
33 The first randomised trial on Early intervention in bipolar disorder Conclusion Treatment in a specialised mood disorder clinic early in the course of bipolar disorder substantially reduces psychiatric re-hospitalisations and increases satisfaction with care. And more so among young patients. and save total net costs. 33
34 Thank you! 34
Transition between inpatient mental health settings and community and care home settings
Guideline Transition between inpatient mental health settings and community and care home settings Economics, Evidence review, Appendix 1 Selecting areas for economic analysis Table of Contents 1 Introduction
More informationTransition between inpatient mental health settings and community and care home settings
Economics, Evidence review, Appendix C1 Selecting areas for economic analysis Guideline Transition between inpatient mental health settings and community and care home settings This report was produced
More informationLithium in bipolar disorders.
Lithium in bipolar disorders. S. Mehdi Samimi Ardestani M.D. Department of Psychiatry, Shahid Beheshti University of Medical Science, Behavioral science research center Iranian psychiatric association,
More informationResubmission. Scottish Medicines Consortium
Scottish Medicines Consortium Resubmission aripiprazole 5mg, 10mg, 15mg, 0mg tablets; 10mg, 15mg orodispersible tablets; 1mg/mL oral solution (Abilify ) No. (498/08) Bristol-Myers Squibb Pharmaceuticals
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationAre rates of pediatric bipolar disorder increasing? Results from a nationwide register study
Kessing et al. International Journal of Bipolar Disorders 2014, 2:10 RESEARCH Open Access Are rates of pediatric bipolar disorder increasing? Results from a nationwide register study Lars Vedel Kessing
More informationTreatment Options in Bipolar Disorder: Lessons from Population-Based Registers with Focus on Lithium Lars Vedel Kessing, MD, DMSc 1,2,
Curr Treat Options Psych (2015) 2:218 228 DOI 10.1007/s40501-015-0047-4 Mood Disorders (S Frangou, Section Editor) Treatment Options in Bipolar Disorder: Lessons from Population-Based Registers with Focus
More informationRISK OF RELAPSE IN AFFECTIVE DISORDERS Table 1 Number of patients with depressive or bipolar disorder according to number of episodes leading to hospi
BRITISH JOURNAL OF PSYCHIATRY (2004), 185, 372^377 Course of illness in depressive and bipolar disorders Naturalistic study, 1994^1999 LARS VEDEL KESSING, METTE GERSTER HANSEN and PER KRAGH ANDERSEN Background
More informationEXPERIENCED STATISTICAL CONSULTANT
G.H.Laier Research & Analysis EXPERIENCED STATISTICAL CONSULTANT Gunnar Hellmund Laier is a dedicated independently minded consultant with natural insights in a multitude of topic areas besides sciences,
More informationSupplementary Methods
Supplementary Materials for Suicidal Behavior During Lithium and Valproate Medication: A Withinindividual Eight Year Prospective Study of 50,000 Patients With Bipolar Disorder Supplementary Methods We
More informationCRITICAL ANALYSIS PROBLEMS
CRITICAL ANALYSIS PROBLEMS MOCK EXAMINATION Paper II 2015 STIMULUS THIS STIMULUS IS NOT TO BE REMOVED FROM THE EXAMINATION ROOM DIRECTIONS To be used as a handout while answering questions. Do not answer
More informationUse of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease A Nationwide Population-Based Study
Research Original Investigation Use of Lithium and Anticonvulsants and the Rate of Chronic Kidney Disease A Nationwide Population-Based Study Lars Vedel Kessing, MD, DMSc; Thomas Alexander Gerds, PhD;
More informationBipolar Disorder Clinical Practice Guideline Summary for Primary Care
Bipolar Disorder Clinical Practice Guideline Summary for Primary Care DIAGNOSIS AND CLINICAL ASSESSMENT Bipolar Disorder is categorized by extreme mood cycling; manifested by periods of euphoria, grandiosity,
More informationChild and Adolescent Psychiatry Trends. ADAMHS Board - 28 Oct 2014
Child and Adolescent Psychiatry Trends ADAMHS Board - 28 Oct 2014 Current Need for Child and Adolescent Psychiatrists There are currently approximately 7400 Child and Adolescent Psychiatrists in Practice
More informationAPPENDIX 33: HEALTH ECONOMICS ECONOMIC EVIDENCE PROFILES
APPENDIX 33: HEALTH ECONOMICS ECONOMIC EVIDENCE PROFILES 1.1 Case identification assessment of adults with bipolar disorder... 2 1.1.1 Clinical/economic question: Mood Disorder Questionnaire (MDQ) versus
More informationWhere to from Here? Evidence-Based Strategies for Treatment of Refractory Depression
Where to from Here? Evidence-Based Strategies for Treatment of Refractory Depression Michael D. Jibson, MD, PhD Professor of Psychiatry University of Michigan Major Depression #1 WHO cause of disability
More informationComparison of the Usefulness of Lithium and Valproate
Review Article CNPT4(2013) 1-5 Comparison of the Usefulness of Lithium and Valproate, M.D., Ph.D. Department of Neuropsychiatry, Oita University Faculty of Medicine ABSTRACT This review shows that lithium
More informationExcellence in psychiatry: hopes and hubris
EXCELLENCE IN PSYCHIATRY: HOPES AND HUBRIS Regent s Park, London A collaboration between Progress and the International Society for Affective Disorders 14th LAP Symposium z Conference Excellence in psychiatry:
More informationThe Pharmacological Management of Bipolar Disorder: An Update
Psychobiology Research Group The Pharmacological Management of Bipolar Disorder: An Update R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon.
More informationClinical Guideline for the Management of Bipolar Disorder in Adults
Clinical Guideline for the Management of Bipolar Disorder in Adults Goal: To improve the quality of life of adults with bipolar disorder Identification and Treatment of Bipolar Disorder Criteria for Diagnosis:
More informationTreatment Options for Bipolar Disorder Contents
Keeping Your Balance Treatment Options for Bipolar Disorder Contents Medication Treatment for Bipolar Disorder 2 Page Medication Record 5 Psychosocial Treatments for Bipolar Disorder 6 Module Summary 8
More informationresources/guidelines-policies/locg.html
BIPOLAR AND RELATED DISORDERS Optum Coverage Determination Guideline Policy Number: BH803BPD0518 Effective Date: May 9, 2018 Table of Contents Page BENEFIT CONSIDERATIONS...1 COVERAGE RATIONALE...1 EVIDENCE-BASED
More informationAging with Bipolar Disorder. Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health
Aging with Bipolar Disorder Neha Jain, MD, FAPA Assistant Professor of Psychiatry, UConn Health Objectives Define bipolar disorder in the elderly Review comorbidities How does it differ from bipolar in
More informationAffective Disorders.
Affective Disorders http://www.bristol.ac.uk/medicalschool/hippocrates/psychethics/ Affective Disorders Depression Mania / Hypomania Bipolar mood disorder Recurrent depression Persistent mood disorders
More informationMood Disorders and Addictions: A shared biology?
Mood Disorders and Addictions: A shared biology? Dr. Paul Stokes Clinical Senior Lecturer, Centre for Affective Disorders, Department of Psychological Medicine Disclosures No relevant disclosures: No paid
More informationOutpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years
Outpatient use of Atypical Antipsychotic Agents in the Pediatric Population Years 2004-2008 Laura Governale, Pharm.D., MBA Team Leader, Drug Utilization Data Analyst Hina Mehta, Pharm.D. Drug Utilization
More informationKing s Research Portal
King s Research Portal DOI: 10.1016/j.encep.2016.04.004 Document Version Peer reviewed version Link to publication record in King's Research Portal Citation for published version (APA): Yang, H., & Young,
More informationAPPENDIX 32: HEALTH ECONOMICS EVIDENCE TABLES
APPENDIX 32: HEALTH ECONOMICS EVIDENCE TABLES 1.1 Case identification and assessment of adults with bipolar disorder... 3 1.2 Pharmacological interventions for mania, hypomania and mixed episodes in adults
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 05 May 2010
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 05 May 2010 LAMICTAL 2 mg, dispersible / chewable tablet B/30 (CIP: 354 581-7) LAMICTAL 5 mg, dispersible / chewable
More informationPsychoeducation for bipolar disorder
Advances in psychiatric treatment (2010), vol. 16, 147 154 doi: 10.1192/apt.bp.108.006403 Psychoeducation for bipolar disorder Daniel Smith, Ian Jones & Sharon Simpson ARTICLE SUMMARY Bipolar disorder
More informationExhibit I-1 Performance Measures. Numerator (general description only)
# Priority Type Performance Measure Core Measures (implement 9/1/09) 1 C OE Hospital readmissions within 7, 30 and 90 days postdischarge 2 C OE Percent of Members prescribed redundant or duplicated antipsychotic
More informationBipolar disorder is also sometimes called manic depression, bipolar affective disorder or bipolar mood disorder.
Bipolar Disorder What is bipolar disorder? Bipolar disorder is also sometimes called manic depression, bipolar affective disorder or bipolar mood disorder. Bipolar disorder is an illness in which there
More informationAmy Edmondson Mulroy, MD
Curriculum Vitae Amy Edmondson Mulroy, MD 7940 Floyd Curl Drive, Suite 700 7940 Floyd Curl Drive, Suite 1020 San Antonio, Texas 78229 San Antonio, Texas 78229 EDUCATION 1997 General Adult Psychiatry Internship
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationMERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) KEY ISSUES
MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES MM11 - High-Dose Antipsychotic Use Guidelines (local guideline) Medicines Management Services aim to ensure that (i) Service users receive their medicines
More informationAiming for recovery for patients with severe or persistent depression a view from secondary care. Chrisvan Koen
Aiming for recovery for patients with severe or persistent depression a view from secondary care Chrisvan Koen Kent and Medway NHS and Social care Partnership trust Persistent depressive disorder F34 Persistent
More informationDifferences in mood instability in patients with bipolar disorder type I and II: a smartphone based study
https://doi.org/10.1186/s40345-019-0141-4 RESEARCH Open Access Differences in mood instability in patients with bipolar disorder type I and II: a smartphone based study Maria Faurholt Jepsen 1*, Mads Frost
More informationDepression Disease Navigation
Depression Disease Navigation The depression disease navigation program is designed to reach out to members who have been diagnosed with major depression disorder. This is accomplished by promoting treatment
More informationDepartment of Psychiatry
Department of Psychiatry RESEARCH WATCH April 2018 - Volume 4, Issue 4 Chief Curators: Awais Aftab & Erin Fulchiero Curators: Christine Collins Heather Wobbe Javier Ponce Terashima Prakash Mishra Rob Siedler
More informationWhat s new in the treatment of bipolar disorder?
What s new in the treatment of bipolar disorder? Dr. David Cousins MRC Clinician Scientist Institute of Neuroscience Newcastle University NCMD 2017 What s new in the treatment of bipolar disorder? Dr.
More informationMood Disorders for Care Coordinators
Mood Disorders for Care Coordinators David A Harrison, MD, PhD Assistant Professor, Dept of Psychiatry & Behavioral Sciences University of Washington School of Medicine Introduction 1 of 3 Mood disorders
More informationA lmost all patients admitted to hospital receive prescribed
4 ORIGINAL ARTICLE The use of prescribing indicators to measure the quality of care in psychiatric inpatients C Paton, P Lelliott... See editorial commentary, p 9 See end of article for authors affiliations...
More informationAssertive outreach in Denmark. Professor Merete Nordentoft Psychiatric Center Copenhagen, Copenhagen University
Assertive outreach in Denmark Professor Merete Nordentoft Psychiatric Center Copenhagen, Copenhagen University mn@dadlnet.dk www.opus-kbh.dk Marie Hoegh Thoegersen, Ph.D. Social Service Administration,
More informationKey Behavioral Health Measures (18 Years and Older)
At WellCare, we value everything you do to deliver quality care for our members your patients to make sure they have a positive health care experience. That s why we ve created this easy-to-use, informative
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Bipolar Depression: Putting the End Goal
More informationBipolar Disorder in Youth
Bipolar Disorder in Youth Janet Wozniak, M.D. Associate Professor of Psychiatry Director, Pediatric Bipolar Disorder Research Program Harvard Medical School Massachusetts General Hospital Pediatric-Onset
More informationMaria Faurholt-Jepsen, 1 Maj Vinberg, 1 Ellen Margrethe Christensen, 1 Mads Frost, 2 Jakob Bardram, 2 Lars Vedel Kessing 1
Open Access To cite: Faurholt-Jepsen M, Vinberg M, Christensen EM, et al. Daily electronic selfmonitoring of subjective and objective symptoms in bipolar disorder the MONARCA trial protocol (MONitoring,
More informationKey Behavioral Measures (17 Years and Younger)
2018 HEDIS At-A-Glance Key Behavioral Measures (17 Years and Younger) At WellCare/Harmony, we value everything you do to deliver quality care for our members your patients to make sure they have a positive
More informationTaking Care: Child and Youth Mental Health TREATMENT OPTIONS
Taking Care: Child and Youth Mental Health TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS With appropriate treatment, more than 80% of people with depression get full relief from their symptoms
More informationTexas Council Endorsed Measurement Strategy
Texas Council Endorsed Measurement Strategy During 2013, the Data Work Group of the Texas Council of Community Centers met to identify a set of clinical quality measures that can be used across the entire
More informationBIPOLAR AND RELATED DISORDERS
BIPOLAR AND RELATED DISORDERS Optum Coverage Determination Guideline Policy Number: BH727BPDCDG_022017 Effective Date: May, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationTaking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS
Taking Care: Child and Youth Mental Health PSYCHOSIS TREATMENT OPTIONS Open Learning Agency 2004 TREATMENT OPTIONS Psychosis is highly treatable, especially if caught early. The prognosis for recovery
More informationManaging Common Mental Health Problems
Managing Common Mental Health Problems Dr John S Parker MBBCh; FCPsych(SA) Dept of Psychiatry and Mental Health, Faculty of Health Sciences, UCT. Lentegeur Psychiatric Hospital SAMA Conference 2016 Universal
More informationNQF Behavioral Health Project Phase II Submitted Measures
0103 Major Depressive Disorder (MDD): Diagnostic Evaluation Percentage of patients aged 18 years and older with a new diagnosis or recurrent episode of MDD who met the DSM-IV criteria during the visit
More informationPediatric Psychopharmacology
Pediatric Psychopharmacology General issues to consider. Pharmacokinetic differences Availability of Clinical Data Psychiatric Disorders can be common in childhood. Early intervention may prevent disorders
More informationSuicide Mortality and Suicide Prevention in Finland
13.9. 2017 Suicide Mortality and Suicide Prevention in Finland Erkki T. Isometsä, MD, PhD Professor of Psychiatry, Department of Psychiatry. University of Helsinki and Helsinki University Hospital. Finland
More informationYour footnote
MANIA Your footnote Your footnote Cipriani A, Barbui C, Salanti G et al. Comparative efficacy and acceptability of antimanic drugs in acute mania: a multiple-treatments meta-analysis. The Lancet 2011;
More informationBipolar disorder. Ian M Anderson, 1 Peter M Haddad, 1 2 Jan Scott 3 4 CLINICAL REVIEW
bmj.com Visit BMJ Group s Psychiatry portal at http://www.bmj.com/specialties/psychiatry Bipolar disorder Ian M Anderson, 1 Peter M Haddad, 1 2 Jan Scott 3 4 1 Neuroscience and Psychiatry Unit, University
More informationPrescribing of high-dose and combined antipsychotics for patients on forensic wards.
POMH-UK Topic 3 baseline May 2007 Prescribing of high-dose and combined antipsychotics for patients on forensic wards. Prepared by the Prescribing Observatory for Mental Health (POMH-UK) for member Healthcare
More information35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child
Stephen M. Strakowski, MD Chart Review: Bipolar Disorder PATIENT INFO 35 Age: Female Sex: 35-year-old woman with Hx of BPII Dx; currently separated from husband; has 1 child Background: SI and hospitalization
More informationKEY BEHAVIORAL MEASURES
2019 HEDIS AT-A-GLANCE: KEY BEHAVIORAL MEASURES (18 Years and Older) At WellCare, we value everything you do to deliver quality care for our members your patients to make sure they have a positive healthcare
More informationHow To Treat Resistant Bipolar Patients
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/clinicians-roundtable/how-to-treat-resistant-bipolar-patients/3560/
More informationLacosamide (Vimpat) for partial-onset epilepsy monotherapy. December 2011
Lacosamide (Vimpat) for partial-onset epilepsy monotherapy This technology summary is based on information available at the time of research and a limited literature search. It is not intended to be a
More informationTreatment for Bipolar Disorder
A Resource for Consumers Treatment for Living with bipolar disorder can be a challenge. With the help of your treatment team, family, friends, and by sticking to a treatment plan, you may be able to better
More informationEarly intervention in Bipolar Disorder
Early intervention in Bipolar Disorder Lakshmi N. Yatham MBBS, FRCPC, MRCPsych Professor of Psychiatry, University of British Columbia, Vancouver, Canada Early Intervention in Bipolar Disorder High Risk
More informationMultiple choice questions: ANSWERS
Multiple choice questions: ANSWERS Chapter 1. Diagnosis in children and adolescents 1. Which of the following statements best describes episodes of mood disorder among young people: c. Affective volatility
More informationDementia Benchmarking Indicators Definitions and Data Sources Manual
Indicators Definitions and Data Sources Manual (September 2015) 1 Contents Page Number Dementia Indicators 3 Indicator Summary Tables 4 General Notes 22 Glossary 23 Appendix 1 Dementia Criteria 24 2 Indicators
More informationGuidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care
Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia
More informationAntipsychotics in Bipolar
Use of Second-Generation Antipsychotics in Bipolar Disorder: A Practical Guide Flavio Guzman, MD Editor Psychopharmacology Institute This practical guide is an update on the use of second-generation antipsychotics
More informationBipolar Disorders in Late Life. Robert C. Young, M.D. Department of Psychiatry Weill Medical College of Cornell University
Bipolar Disorders in Late Life Robert C. Young, M.D. Department of Psychiatry Weill Medical College of Cornell University 1 Self-Assessment Question 1 As reported by Himmelhoch et al in 1980, comorbid
More informationResearch Protocol for REAP Bipolar Disorder (REAP-BD)
Research Protocol for REAP Bipolar Disorder (REAP-BD) Summary REAP-BD survey will focus on the prescription patterns on bipolar disorder. Both inpatients and outpatients with bipolar disorder will be enrolled.
More informationHow to treat depression with medication: Some rules of thumb
How to treat depression with medication: Some rules of thumb R. Hamish McAllister-Williams, MD, PhD, FRCPsych Reader in Clinical Psychopharmacology Newcastle University Hon. Consultant Psychiatrist Regional
More informationPractical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current Clinical Guidelines
SECOND-GENERATION ANTIPSYCHOTICS IN BIPOLAR DISORDER Practical Guide to Long-Term Pharmacotherapy in Bipolar Disorder: An Updated Synthesis of Current s Flavio Guzman, MD Editor Psychopharmacology Institute
More informationFaurholt-Jepsen et al. Trials (2017) 18:277 DOI /s
Faurholt-Jepsen et al. Trials (2017) 18:277 DOI 10.1186/s13063-017-2015-3 STUDY PROTOCOL Reducing the rate and duration of Re- ADMISsions among patients with unipolar disorder and bipolar disorder using
More information1. Family aggregation and long-term outcome of psychopathology in children and adolescents in the Danish Three Generation Study (3GS)
Aalborg CAP research programme 2016 1. Family aggregation and long-term outcome of psychopathology in children and adolescents in the Danish Three Generation Study (3GS) Objectives: Study of the aggregation
More informationIndicators of suicide among people with serious mental illness
Indicators of suicide among people with serious mental illness OECD/Denmark Mette Jørgensen, Søren Paaske Johnsen, Poul Erik Hansen, Katrine Grau, Jette Bauer and Jan Mainz Friday 14th November 2014 Agenda
More informationLong-term Treatment in Bipolar Disorder: Fall 2015 Update
Long-term Treatment in Bipolar Disorder: Fall 2015 Update Roy H. Perlis, MD MSc Center for Experimental Drugs and Diagnostics Massachusetts General Hospital Harvard Medical School rperlis@partners.org
More informationJennifer M. Lytle, M.D., M.P.H. Clinical Trials of the Rockies 3955 E. Exposition Avenue, Suite 100 Denver, CO Tel.
CONTACT INFORMATION: Site Selection and Information: Bobbie Theodore, Site Liaison Tel. (916) 939-6696 Fax (208) 575-3169 Email: clinicaltrials@alliancesites.com EDUCATION: Jennifer M. Lytle, M.D., M.P.H.
More informationMania in the Nordic countries: Patients and treatment in the acute phase of the EMBLEM study
Mania in the Nordic countries: Patients and treatment in the acute phase of the EMBLEM study JENS KNUD LARSEN, VIBEKE PORSDAL, TROND F. AARRE, HANNU J. KOPONEN, JORMA AARNIO, OLE KRISTIAN KLEIVENES, THE
More informationA Critical Review of. Current Guidelines for Bipolar Disorder. R. Hamish McAllister-Williams, MD, PhD, MRCPsych
A Critical Review of Psychobiology Research Group Current Guidelines for Bipolar Disorder R. Hamish McAllister-Williams, MD, PhD, MRCPsych Reader in Clinical Psychopharmacology University of Newcastle
More informationCASE 5 - Toy & Klamen CASE FILES: Psychiatry
CASE 5 - Toy & Klamen CASE FILES: Psychiatry A 14-year-old boy is brought to the emergency department after being found in the basement of his home by his parents during the middle of a school day. The
More informationSchizoaffective Disorder
Schizoaffective Disorder This leaflet is designed to help understand schizoaffective disorder. It may be useful if: you have a diagnosis of schizoaffective disorder you are worried that you may have this
More informationPrescribing medications for people with a personality disorder A service evaluation of a community mental health team
Prescribing medications for people with a personality disorder A service evaluation of a community mental health team Dr Umama Khan, Consultant Psychiatrist Dr Venkatesh Ballagere, Specialist Registrar
More informationSTEP THERAPY CRITERIA
DRUG CLASS PRODUCTS) BRAND NAME (BRAND ONLY) (generic) STEP THERAPY CRITERIA ATYPICAL ANTIPSYCHOTICS (BRAND ONLY ABILIFY (AL TABLET & AL SOLUTION ONLY) (aripiprazole) FANAPT (BRAND ONLY) (iloperidone)
More informationScreening for Depression and Suicide Risk Assessment
Screening for Depression and Suicide Risk Assessment Karl Rosston, LCSW Suicide Prevention Coordinator (406) 444-3349 krosston@mt.gov Updated: July, 2017 Suicide Fact Sheet Center for Disease Control WISQARS
More informationRoles of primary care physicians in managing bipolar disorders in adults
CPG UPDATE Roles of primary care physicians in managing bipolar disorders in adults Awaluddin A, Jali N, Bahari R, Jamil Z, Haron N on behalf of Development Group Clinical Practice Guidelines Management
More informationJournal Club Samir Patel, MD MPH 03/08/2013
Journal Club Samir Patel, MD MPH 03/08/2013 Common Associated with negative outcomes Inadequately treated Problems with medication Can physical activity ii can ameliorate depressive symptoms? Bridle C,
More informationIntegrating Behavioral Health into Primary Care: Collaborative-Care Models
Integrating Behavioral Health into Primary Care: Collaborative-Care Models Presented at the National Health Policy Forum September 17 th, 2013 Marc Avery, MD Clinical Associate Professor Associate Director
More informationStudy population Patients in the UK, with moderate and severe depression, and within the age range 18 to 93 years.
Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK Borghi J, Guest J F Record Status This is a critical abstract
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationLithium prescribing trends: Review
Review article: Lithium prescribing trends: Review *Dr. Ivan Netto, Dr. Ranjit Patil,** Dr. Prathamesh Kamble, Dr. Saurabh Sonkusare *Consultant Psychiatrist, E-10 Parmar Plaza Clinic, Fatimanagar, Pune,
More informationProf. dr. Peter Goossens, MANP FEANS. A.W.M.M. Stevens, MD M.H.G. Groot lipman RN Msc
Show Yourself : The development of an intervention to show professionals at an admission ward the patients euthymic being during severe mania or depression Prof. dr. Peter Goossens, MANP FEANS A.W.M.M.
More informationMood Disorders-Major Depression
Mood Disorders Paula Gibbs, MD Assistant Professor Department of Psychiatry Medical Director of 5West Med-Psych University of Utah Hospitals and Clinics Mood Disorders-Major Depression Key Points for Major
More informationPediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form
Pediatric Behavioral Health Medication Initiative Prior Authorization (PA) Request Form Please fax form to 617.673.0988 or mail to Tufts Health Plan, 705 Mount Auburn Street, Watertown, MA 02472, Attn:
More informationObjectives. Objectives. A practice review. 02-Nov-16 MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS
MAJOR DEPRESSIVE DISORDER: NEW DEVELOPMENTS AND PRACTICAL IMPLICATIONS Jon-Paul Khoo What is treatment resistance really? Database review 328 consecutive non-remitted MDD patients referred for private
More informationGuidelines for the Utilization of Psychotropic Medications for Children in Foster Care. Illinois Department of Children and Family Services
Guidelines for the Utilization of Psychotropic Medications for Children in Foster Care Illinois Department of Children and Family Services Introduction With few exceptions, children and adolescents in
More informationMENTAL HEALTH SERVICES 2010 MEDICATION
MENTAL HEALTH SERVICES 2010 INTRODUCTION MEDICATION Under the Mental Health Act 2001 the Inspectorate carries out a review of mental health services in the state and furnishes a report on the quality of
More informationMedical Treatment of Problem Gambling. Donald W. Black, M.D. Roy J. and Lucille A. Carver College of Medicine Department of Psychiatry
Medical Treatment of Problem Gambling Donald W. Black, M.D. Roy J. and Lucille A. Carver College of Medicine Department of Psychiatry Disclosures Research Support: Forest Labs Nellie Ball Trust Fund National
More informationUnitedHealthcare Community (UHCCP) Louisiana Clinical Program Guidelines Record Supplemental Tool
December-18 UnitedHealthcare Community (UHCCP) Louisiana Clinical Program Guidelines Record Supplemental Tool Facility Name: Primary Dx: Member Gender: Member Age: Reviewer Name: Date of Facility Review:
More information